Risk factors and treatment outcomes of new contralateral upper urinary urothelial carcinoma after nephroureterectomy: The experiences of a large Chinese center

Journal of Cancer Research and Clinical Oncology

Volumn 140, Issue 3, 2014, Pages 477-485

  Fang, Dong ^a   Zhang, Lei ^a   Li, Xuesong ^a   Xiong, Gengyan ^a   Chen, Xiaopeng ^a,b   Han, Wenke ^a   He, Zhisong ^a   Zhou, Liqun ^a  

^a PEKING UNIVERSITY FIRST HOSPITAL   (China)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Chronic kidney disease (CKD); Contralateral; Prognosis; Radical nephroureterectomy (RNU); Renal transplant; Upper tract urothelial carcinoma (UTUC)

Indexed keywords

ARISTOLOCHIC ACID; HERBACEOUS AGENT;

AGE; AGED; ARTICLE; CANCER LOCALIZATION; CANCER RISK; CANCER SIZE; CANCER SURVIVAL; CHINA; CONTRALATERAL UPPER TRACT UROTHELIAL CARCINOMA; DISEASE SEVERITY; FEMALE; GRAFT RECIPIENT; HEMATURIA; HUMAN; KIDNEY FAILURE; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; NEPHRON SPARING SURGERY; NEPHROURETERECTOMY; PREOPERATIVE PERIOD; PRIORITY JOURNAL; REOPERATION; RETROSPECTIVE STUDY; RISK ASSESSMENT; SECOND CANCER; TRANSITIONAL CELL CARCINOMA; TREATMENT OUTCOME; URETER;

AGED; ARISTOLOCHIC ACIDS; CARCINOGENS; CARCINOMA, TRANSITIONAL CELL; CHINA; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; KIDNEY NEOPLASMS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; NEPHRECTOMY; RETROSPECTIVE STUDIES; RISK FACTORS; TREATMENT OUTCOME; URETER; UROLOGIC NEOPLASMS;

EID: 84896701768     PISSN: 01715216     EISSN: 14321335     Source Type: Journal    
DOI: 10.1007/s00432-014-1585-7     Document Type: Article

References (29)

1. Bloom NA, Vidone RA, Lytton B (1970) Primary carcinoma of the ureter: a report of 102 new cases. J Urol 103(5):590-598
2. Charbit L, Gendreau MC, Mee S, Cukier J (1991) Tumors of the upper urinary tract: 10 years of experience. J Urol 146(5):1243-1246
3. Chen CH, Dickman KG, Huang CY, Moriya M, Shun CT, Tai HC, Huang KH, Wang SM, Lee YJ, Grollman AP, Pu YS (2013) Aristolochic acid-induced upper tract urothelial carcinoma in Taiwan: clinical characteristics and outcomes. Int J Cancer 133(1):14-20
4. Colin P, Ouzzane A, Pignot G, Ravier E, Crouzet S, Ariane MM, Audouin M, Neuzillet Y, Albouy B, Hurel S, Saint F, Guillotreau J, Guy L, Bigot P, De La Taille A, Arroua F, Marchand C, Matte A, Fais PO, Roupret M (2012) Comparison of oncological outcomes after segmental ureterectomy or radical nephroureterectomy in urothelial carcinomas of the upper urinary tract: results from a large French multicentre study. BJU Int 110(8):1134-1141
5. Cosyns JP, Jadoul M, Squifflet JP, Wese FX, van Ypersele de Strihou C (1999) Urothelial lesions in Chinese-herb nephropathy. Am J Kidney Dis 33(6):1011-1017
6. Cummings KB (1980) Nephroureterectomy: rationale in the management of transitional cell carcinoma of the upper urinary tract. Urol Clin N Am 7(3):569-578
7. Gadzinski AJ, Roberts WW, Faerber GJ, Wolf JS Jr (2010) Long-term outcomes of nephroureterectomy versus endoscopic management for upper tract urothelial carcinoma. J Urol 183(6):2148-2153
8. Habuchi T, Takahashi R, Yamada H, Kakehi Y, Sugiyama T, Yoshida O (1993) Metachronous multifocal development of urothelial cancers by intraluminal seeding. Lancet 342(8879):1087-1088
9. Hafner C, Knuechel R, Zanardo L, Dietmaier W, Blaszyk H, Cheville J, Hofstaedter F, Hartmann A (2001) Evidence for oligoclonality and tumor spread by intraluminal seeding in multifocal urothelial carcinomas of the upper and lower urinary tract. Oncogene 20(35):4910-4915
10. Holmang S, Johansson SL (2006) Bilateral metachronous ureteral and renal pelvic carcinomas: incidence, clinical presentation, histopathology, treatment and outcome. J Urol 175(1):69-72 (discussion 72-63)
11. Hou HJ, Xiao J, Tian Y (2013) Contralateral nephroureterectomy for renal transplant recipients with unilateral upper urinary tract transitional cell carcinoma: a report of 12 cases. Transplant Proc 45(6):2203-2206
12. Kang CH, Yu TJ, Hsieh HH, Yang JW, Shu K, Huang CC, Chiang PH, Shiue YL (2003) The development of bladder tumors and contralateral upper urinary tract tumors after primary transitional cell carcinoma of the upper urinary tract. Cancer 98(8):1620-1626
13. Li CC, Chang TH, Wu WJ, Ke HL, Huang SP, Tsai PC, Chang SJ, Shen JT, Chou YH, Huang CH (2008a) Significant predictive factors for prognosis of primary upper urinary tract cancer after radical nephroureterectomy in Taiwanese patients. Eur Urol 54(5):1127-1134
14. Li XB, Xing NZ, Wang Y, Hu XP, Yin H, Zhang XD (2008b) Transitional cell carcinoma in renal transplant recipients: a single center experience. Int J Urol 15(1):53-57
15. Li HZ, Xia M, Han Y, Xu XG, Zhang YS (2009) De novo urothelial carcinoma in kidney transplantation patients with end-stage aristolochic acid nephropathy in China. Urol Int 83(2):200-205
16. Li WM, Shen JT, Li CC, Ke HL, Wei YC, Wu WJ, Chou YH, Huang CH (2010) Oncologic outcomes following three different approaches to the distal ureter and bladder cuff in nephroureterectomy for primary upper urinary tract urothelial carcinoma. Eur Urol 57(6):963-969
17. Liao CH, Chueh SC, Lai MK, Chen J (2004) Transitional cell carcinoma in renal transplant recipients. Transplant Proc 36(7):2152-2153
18. Ma YC, Zuo L, Chen JH, Luo Q, Yu XQ, Li Y, Xu JS, Huang SM, Wang LN, Huang W, Wang M, Xu GB, Wang HY (2006) Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease. J Am Soc Nephrol 17(10):2937-2944
19. Millan-Rodriguez F, Chechile-Toniolo G, Salvador-Bayarri J, Huguet-Perez J, Vicente-Rodriguez J (2000) Upper urinary tract tumors after primary superficial bladder tumors: prognostic factors and risk groups. J Urol 164(4):1183-1187
20. Miyake H, Hara I, Kamidono S, Eto H (2004) Multifocal transitional cell carcinoma of the bladder and upper urinary tract: molecular screening of clonal origin by characterizing CD44 alternative splicing patterns. J Urol 172(3):1127-1129
21. Mufti GR, Gove JR, Badenoch DF, Fowler CG, Tiptaft RC, England HR, Paris AM, Singh M, Hall MH, Blandy JP (1989) Transitional cell carcinoma of the renal pelvis and ureter. Br J Urol 63(2):135-140
22. Nakazawa R, Miyano S, Sasaki H, Kudo H, Kimura K, Chikaraishi T (2011) Synchronous bilateral urothelial cancer in a kidney recipient. Int J Urol 18(12):847-850
23. Nortier JL, Martinez MC, Schmeiser HH, Arlt VM, Bieler CA, Petein M, Depierreux MF, De Pauw L, Abramowicz D, Vereerstraeten P, Vanherweghem JL (2000) Urothelial carcinoma associated with the use of a Chinese herb (Aristolochia fangchi). N Engl J Med 342(23):1686-1692
24. Novara G, De Marco V, Dalpiaz O, Galfano A, Bouygues V, Gardiman M, Martignoni G, Patard JJ, Artibani W, Ficarra V (2009) Independent predictors of contralateral metachronous upper urinary tract transitional cell carcinoma after nephroureterectomy: multi-institutional dataset from three European centers. Int J Urol 16(2):187-191
25. Roupret M, Babjuk M, Comperat E, Zigeuner R, Sylvester R, Burger M, Cowan N, Bohle A, Van Rhijn BW, Kaasinen E, Palou J, Shariat SF (2013) European guidelines on upper tract urothelial carcinomas: 2013 update. Eur Urol 63(6):1059-1071
26. Stewart JH, Vajdic CM, van Leeuwen MT, Amin J, Webster AC, Chapman JR, McDonald SP, Grulich AE, McCredie MR (2009) The pattern of excess cancer in dialysis and transplantation. Nephrol Dial Transplant 24(10):3225-3231
27. Wu MJ, Lian JD, Yang CR, Cheng CH, Chen CH, Lee WC, Shu KH, Tang MJ (2004) High cumulative incidence of urinary tract transitional cell carcinoma after kidney transplantation in Taiwan. Am J Kidney Dis 43(6):1091-1097
28. Wu CF, Chang PL, Chen CS, Chuang CK, Weng HH, Pang ST (2006) The outcome of patients on dialysis with upper urinary tract transitional cell carcinoma. J Urol 176(2):477-481
29. Xiong G, Chen X, Li X, Fang D, Zhang L, Yang L, Zhang L, Yao L, He Z, Zhou L (2013) Prevalence and factors associated with baseline chronic kidney disease in China: a 10-year study of 785 upper urinary tract urothelial carcinoma patients. J Formos Med Assoc. doi: 10.1016/j.jfma.2013.04.001. [Epub ahead of print]